NEW National Clinical Director for Innovation for NHS England

pharmafield logo - pharma news

A new National Clinical Director for Innovation has been appointed by NHS England this week, to provide clinical leadership and support in delivering improved health outcomes for the UK.

The new recruit, Professor Tony Young PhD, FRCS (Urol) has called it an “honour” to be appointed to the role, and will focus on the five domains outlined in this year’s NHS Outcomes Framework document.

It is hoped Professor Young will generate economic growth through innovation and drive the uptake of proven innovations across the healthcare system.

Professor Young has said, “By encouraging economic growth and becoming early adopters of the latest innovations, we can rise to the challenge and help transform patient care and experience.”

“I look forward to working with clinicians to help make innovation happen and bring the latest advances in technology and improvements in care pathways. The challenges we face as a national health system, particularly in the management of chronic disease are piled high.” he said.

Deputy Medical Director for NHS England, Dr Mike Bewick, is extremely excited to work with Professor Young, and has said, “Tony will be a great asset in helping move this agenda forward and we are looking forward to him joining the team.”

The Professor is currently a practicing Consultant Urological Surgeon at Southend University Hospital and Director of Medical Innovation at Anglia Ruskin University, which will remain his posts during his time on secondment to NHS England.